0001387131-23-010585.txt : 20230830 0001387131-23-010585.hdr.sgml : 20230830 20230829210857 ACCESSION NUMBER: 0001387131-23-010585 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230829 EFFECTIVENESS DATE: 20230830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: World Funds Trust CENTRAL INDEX KEY: 0001396092 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: N-PX SEC ACT: 1940 Act SEC FILE NUMBER: 811-22172 FILM NUMBER: 231223562 BUSINESS ADDRESS: STREET 1: 8730 STONY POINT PARKWAY STREET 2: SUITE 205 CITY: RICHMOND STATE: VA ZIP: 23235 BUSINESS PHONE: 804-267-7400 MAIL ADDRESS: STREET 1: 8730 STONY POINT PARKWAY STREET 2: SUITE 205 CITY: RICHMOND STATE: VA ZIP: 23235 FORMER COMPANY: FORMER CONFORMED NAME: Abacus World Funds Trust DATE OF NAME CHANGE: 20070410

0001396092 S000038882 Perkins Discovery Fund

C000119646 Investor PDFDX

N-PX 1 perkins-npx_063023.htm ANNUAL REPORT OF PROXY VOTING RECORD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number:	811-22172
Exact name of registrant as specified in charter:	World Funds Trust
Address of principal executive offices:	8730 Stony Point Parkway, Suite 205 Richmond, VA 23235
Name and address of agent for service:	The Corporation Trust Company 1209 Orange Street Wilmington, DE 19801
	with a copy to: Practus, LLP 11300 Tomahawk Creek Parkway, Suite 310 Leawood, KS 66211
Registrant's telephone number, including area code:	800-267-7400
Date of fiscal year end:	March 31^st
Date of reporting period:	July 1, 2022 to June 30, 2023

Item 1. Proxy Voting Record.

Perkins Discovery Fund
--------------------------------------------------------------------------------------------------------------------------
AIRGAIN INC Agenda Number: 935860836
--------------------------------------------------------------------------------------------------------------------------
Security: 00938A104 Meeting Type: Annual
Ticker: AIRG Meeting Date: 21-Jun-2023
ISIN: US00938A1043
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1.1 Election of Class I Director for a three-year term to Mgmt For For
expire at the 2026 annual meeting: James K. Sims

1.2 Election of Class I Director for a three-year term to Mgmt For For
expire at the 2026 annual meeting: Tzau-Jin Chung

2. To consider and vote upon the ratification of the Mgmt For For
appointment of Grant Thornton LLP as our independent
registered public accounting firm for the fiscal year
ending December 31, 2023.

3. To consider and vote upon, on an advisory basis, the Mgmt For For
compensation of our named executive officers as
disclosed in this proxy statement pursuant to the
compensation disclosure rules of the Securities and
Exchange Commission.

--------------------------------------------------------------------------------------------------------------------------
AKOUSTIS TECHNOLOGIES, INC. Agenda Number: 935714851
--------------------------------------------------------------------------------------------------------------------------
Security: 00973N102 Meeting Type: Annual
Ticker: AKTS Meeting Date: 10-Nov-2022
ISIN: US00973N1028
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Steven P. DenBaars Mgmt For For
Arthur E. Geiss Mgmt For For
J. Michael McGuire Mgmt For For
Jeffrey K. McMahon Mgmt For For
Jerry D. Neal Mgmt For For
Suzanne B. Rudy Mgmt For For
Jeffrey B. Shealy Mgmt For For

2. Proposal to approve, on a non-binding, advisory basis, Mgmt For For
the compensation paid to our named executive officers.

3. Proposal to approve, as required by Nasdaq Marketplace Mgmt For For
Rule 5635(d), the potential issuance of shares of the
Company's common stock in respect of the Company's
6.0% Convertible Senior Notes due 2027 (the "2027
Notes") exceeding 19.99% of the number of shares of
common stock outstanding at the time of the issuance
of the 2027 Notes, including upon the conversion of
the 2027 Notes, upon payment of interest thereon, and
upon certain make-whole payments.

4. Proposal to approve an amendment to the Company's 2018 Mgmt For For
Stock Incentive Plan to increase the number of shares
reserved for issuance thereunder from 6,000,000 to
12,000,000 shares.

5. Proposal to approve an amendment to the Company's Mgmt For For
Certificate of Incorporation increasing the number of
authorized shares of common stock from 100,000,000 to
125,000,000 shares.

6. Proposal to approve an amendment to the Company's Mgmt For For
Certificate of Incorporation to update the exculpation
provision to limit the liability of certain officers
of the Company as permitted by recent amendments to
Delaware law.

7. Proposal to ratify the appointment of Marcum LLP as Mgmt For For
the Company's independent registered public accounting
firm for the fiscal year ending June 30, 2023.

--------------------------------------------------------------------------------------------------------------------------
ANI PHARMACEUTICALS, INC. Agenda Number: 935822521
--------------------------------------------------------------------------------------------------------------------------
Security: 00182C103 Meeting Type: Annual
Ticker: ANIP Meeting Date: 23-May-2023
ISIN: US00182C1036
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Robert E. Brown, Jr. Mgmt For For

1b. Election of Director: Thomas Haughey Mgmt For For

1c. Election of Director: Nikhil Lalwani Mgmt For For

1d. Election of Director: David B. Nash, M.D., M.B.A. Mgmt For For

1e. Election of Director: Antonio R. Pera Mgmt For For

1f. Election of Director: Renee P. Tannenbaum, Pharm.D. Mgmt For For

1g. Election of Director: Muthusamy Shanmugam Mgmt For For

1h. Election of Director: Jeanne A. Thoma Mgmt For For

1i. Election of Director: Patrick D. Walsh Mgmt For For

2. To ratify the appointment of EisnerAmper LLP as the Mgmt For For
Company's independent registered public accounting
firm for the year ending December 31, 2023.

3. To approve the compensation of the Company's named Mgmt For For
executive officers, on an advisory basis.

4. To approve an amendment to the Amended and Restated Mgmt For For
2022 Stock Incentive Plan.

--------------------------------------------------------------------------------------------------------------------------
ASURE SOFTWARE, INC. Agenda Number: 935838550
--------------------------------------------------------------------------------------------------------------------------
Security: 04649U102 Meeting Type: Annual
Ticker: ASUR Meeting Date: 15-May-2023
ISIN: US04649U1025
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Benjamin Allen Mgmt For For
W. Carl Drew Mgmt For For
Daniel Gill Mgmt For For
Patrick Goepel Mgmt For For
Grace Lee Mgmt For For
Bradford Oberwager Mgmt For For
Bjorn Reynolds Mgmt For For

2. To ratify the Audit Committee's appointment of Marcum Mgmt For For
LLP as our independent registered public accounting
firm for the year ending December 31, 2023.

3. To approve, on a non-binding advisory basis, the Mgmt For For
compensation of our named executive officers.

--------------------------------------------------------------------------------------------------------------------------
ATRICURE, INC. Agenda Number: 935809268
--------------------------------------------------------------------------------------------------------------------------
Security: 04963C209 Meeting Type: Annual
Ticker: ATRC Meeting Date: 25-May-2023
ISIN: US04963C2098
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Michael H. Carrel Mgmt For For

1b. Election of Director: Regina E. Groves Mgmt For For

1c. Election of Director: B. Kristine Johnson Mgmt For For

1d. Election of Director: Karen N. Prange Mgmt For For

1e. Election of Director: Deborah H. Telman Mgmt For For

1f. Election of Director: Sven A. Wehrwein Mgmt For For

1g. Election of Director: Robert S. White Mgmt For For

1h. Election of Director: Maggie Yuen Mgmt For For

2. Proposal to ratify the appointment of Deloitte & Mgmt For For
Touche LLP as independent registered public accounting
firm for the fiscal year ending December 31, 2023.

3. Proposal to approve the AtriCure, Inc. 2023 Stock Mgmt For For
Incentive Plan.

4. Proposal to amend the AtriCure, Inc. 2018 Employee Mgmt For For
Stock Purchase Plan to increase the number of shares
of common stock authorized for issuance thereunder by
750,000.

5. Advisory vote on the compensation of our named Mgmt For For
executive officers as disclosed in the proxy statement
for the 2023 Annual Meeting.

--------------------------------------------------------------------------------------------------------------------------
CANTALOUPE INC. Agenda Number: 935729686
--------------------------------------------------------------------------------------------------------------------------
Security: 138103106 Meeting Type: Annual
Ticker: CTLP Meeting Date: 30-Nov-2022
ISIN: US1381031061
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Lisa P. Baird Mgmt For For

1b. Election of Director: Douglas G. Bergeron Mgmt For For

1c. Election of Director: Ian Harris Mgmt For For

1d. Election of Director: Jacob Lamm Mgmt For For

1e. Election of Director: Michael K. Passilla Mgmt For For

1f. Election of Director: Ellen Richey Mgmt For For

1g. Election of Director: Anne M. Smalling Mgmt For For

1h. Election of Director: Ravi Venkatesan Mgmt For For

1i. Election of Director: Shannon S. Warren Mgmt For For

2. Ratification of the appointment of BDO USA, LLP as the Mgmt For For
independent registered public accounting firm of the
Company for fiscal year ending June 30, 2023.

3. Advisory vote on named executive officer compensation. Mgmt For For

4. Approval of an amendment to the Company's 2018 Equity Mgmt For For
Incentive Plan.

--------------------------------------------------------------------------------------------------------------------------
CARDIOVASCULAR SYSTEMS, INC. Agenda Number: 935713708
--------------------------------------------------------------------------------------------------------------------------
Security: 141619106 Meeting Type: Annual
Ticker: CSII Meeting Date: 08-Nov-2022
ISIN: US1416191062
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Class II Director to hold office until the Mgmt For For
2025 Annual Meeting: Scott R. Ward

1b. Election of Class II Director to hold office until the Mgmt For For
2025 Annual Meeting: Kelvin Womack

2. To ratify the appointment of PricewaterhouseCoopers Mgmt For For
LLP as the independent registered public accounting
firm of the Company for its fiscal year ending June
30, 2023.

3. To approve, on an advisory basis, the compensation Mgmt For For
paid to our named executive officers as disclosed in
the proxy statement.

--------------------------------------------------------------------------------------------------------------------------
CRYOPORT, INC. Agenda Number: 935793768
--------------------------------------------------------------------------------------------------------------------------
Security: 229050307 Meeting Type: Annual
Ticker: CYRX Meeting Date: 12-May-2023
ISIN: US2290503075
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Linda Baddour Mgmt For For
Richard Berman Mgmt For For
Daniel Hancock Mgmt For For
Robert Hariri MD, PhD Mgmt For For
Ram M. Jagannath Mgmt For For
Ramkumar Mandalam, PhD Mgmt For For
Jerrell W. Shelton Mgmt For For
Edward Zecchini Mgmt For For

2. To ratify the appointment of Deloitte & Touche LLP as Mgmt For For
the independent registered public accounting firm of
the Company and its subsidiaries for the year ending
December 31, 2023.

3. To approve, on an advisory basis, the compensation of Mgmt For For
the named executive officers, as disclosed in this
Proxy Statement.

--------------------------------------------------------------------------------------------------------------------------
DIGI INTERNATIONAL INC. Agenda Number: 935749614
--------------------------------------------------------------------------------------------------------------------------
Security: 253798102 Meeting Type: Annual
Ticker: DGII Meeting Date: 27-Jan-2023
ISIN: US2537981027
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Satbir Khanuja, Ph.D. Mgmt For For

1b. Election of Director: Ronald E. Konezny Mgmt For For

2. Company proposal to approve, on a non-binding advisory Mgmt For For
basis, the compensation paid to named executive
officers.

3. Company proposal to ratify the appointment of Deloitte Mgmt For For
& Touche LLP as independent registered public
accounting firm of the company for the fiscal year
ending September 30, 2023.

4. Company proposal to approve the amendment and Mgmt For For
restatement of the Digi International Inc. 2021
Omnibus Incentive Plan.

--------------------------------------------------------------------------------------------------------------------------
EPLUS INC. Agenda Number: 935693514
--------------------------------------------------------------------------------------------------------------------------
Security: 294268107 Meeting Type: Annual
Ticker: PLUS Meeting Date: 15-Sep-2022
ISIN: US2942681071
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1.1 Election of Director: BRUCE M. BOWEN Mgmt For For

1.2 Election of Director: JOHN E. CALLIES Mgmt For For

1.3 Election of Director: C. THOMAS FAULDERS, III Mgmt For For

1.4 Election of Director: ERIC D. HOVDE Mgmt For For

1.5 Election of Director: IRA A. HUNT, III Mgmt For For

1.6 Election of Director: MARK P. MARRON Mgmt For For

1.7 Election of Director: MAUREEN F. MORRISON Mgmt For For

1.8 Election of Director: BEN XIANG Mgmt For For

2. Advisory vote (non-binding) on named executive officer Mgmt For For
compensation, as disclosed in the proxy statement.

3. Proposal to ratify the selection of Deloitte & Touche Mgmt For For
LLP as our independent registered public accounting
firm for fiscal year 2023.

4. To approve the 2022 Employee Stock Purchase Plan. Mgmt For For

5. Advisory vote (non-binding) on the frequency of future Mgmt 1 Year For
advisory votes to approve named executive officer
compensation.

--------------------------------------------------------------------------------------------------------------------------
EXAGEN INC Agenda Number: 935843424
--------------------------------------------------------------------------------------------------------------------------
Security: 30068X103 Meeting Type: Annual
Ticker: XGN Meeting Date: 09-Jun-2023
ISIN: US30068X1037
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1.1 Election of Class I Director: Brian Birk Mgmt For For

1.2 Election of Class I Director: Tina S. Nova, Ph.D. Mgmt For For

1.3 Election of Class I Director: Ebetuel Pallares, Ph.D. Mgmt For For

2. To ratify the appointment of BDO USA, LLP as the Mgmt For For
independent registered public accounting firm of
Exagen Inc. for the fiscal year ending December 31,
2023.

--------------------------------------------------------------------------------------------------------------------------
FLEXSHOPPER INC. Agenda Number: 935745806
--------------------------------------------------------------------------------------------------------------------------
Security: 33939J303 Meeting Type: Annual
Ticker: FPAY Meeting Date: 30-Dec-2022
ISIN: US33939J3032
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
James D. Allen Mgmt For For
Howard S. Dvorkin Mgmt For For
Sean Hinze Mgmt For For
T. Scott King Mgmt For For
Thomas O. Katz Mgmt For For

2. Approval, on a non-binding basis, of the compensation Mgmt For For
paid to our named executive officers.

3. Ratification of appointment of independent registered Mgmt For For
public accounting firm.

--------------------------------------------------------------------------------------------------------------------------
FORTRESS BIOTECH, INC. Agenda Number: 935789442
--------------------------------------------------------------------------------------------------------------------------
Security: 34960Q109 Meeting Type: Special
Ticker: FBIO Meeting Date: 10-Apr-2023
ISIN: US34960Q1094
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. Approval to Issue Rights to Acquire Contingent Mgmt For For
Subsidiary Securities in Certain Subsidiaries in Order
to Satisfy the Requirements of NASDAQ Listing Rule
5635(c).

--------------------------------------------------------------------------------------------------------------------------
FORTRESS BIOTECH, INC. Agenda Number: 935859453
--------------------------------------------------------------------------------------------------------------------------
Security: 34960Q109 Meeting Type: Annual
Ticker: FBIO Meeting Date: 21-Jun-2023
ISIN: US34960Q1094
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Lindsay A. Rosenwald MD Mgmt For For
Michael S. Weiss Mgmt For For
Jimmie Harvey, Jr. M.D. Mgmt For For
Malcolm Hoenlein Mgmt For For
Dov Klein, CPA Mgmt For For
J. Jay Lobell Mgmt For For
Eric K. Rowinsky, M.D. Mgmt For For
Kevin L. Lorenz, J.D. Mgmt For For
Lucy Lu, M.D. Mgmt For For

2. Ratification of the appointment of KPMG LLP as Mgmt For For
Fortress Biotech, Inc.'s independent registered public
accounting firm for the fiscal year ending December
31, 2023.

3. Amendment of the 2013 Stock Incentive Plan, as Mgmt For For
amended, of Fortress Biotech, Inc. to increase the
number of shares of Common Stock issuable thereunder
from 16,000,000 to 23,000,000 and extend the term of
the plan to December 31, 2033.

4. Amendment of the 2012 Employee Stock Purchase Plan, as Mgmt For For
amended, of Fortress Biotech, Inc. to increase the
number of shares of Common Stock issuable thereunder
from 1,000,000 to 2,000,000.

--------------------------------------------------------------------------------------------------------------------------
INUVO, INC. Agenda Number: 935857865
--------------------------------------------------------------------------------------------------------------------------
Security: 46122W204 Meeting Type: Annual
Ticker: INUV Meeting Date: 15-Jun-2023
ISIN: US46122W2044
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1.1 Election of Class III Director: Charles D. Morgan Mgmt For For

1.2 Election of Class III Director: Kenneth E. Lee Mgmt For For

2. The ratification of the appointment of EisnerAmper, Mgmt For For
LLP as the Company's independent registered public
accounting firm.

3. An advisory vote on the frequency of future advisory Mgmt 1 Year Against
votes on executive compensation.

--------------------------------------------------------------------------------------------------------------------------
ISORAY, INC. Agenda Number: 935735300
--------------------------------------------------------------------------------------------------------------------------
Security: 46489V104 Meeting Type: Annual
Ticker: ISR Meeting Date: 27-Jan-2023
ISIN: US46489V1044
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. To consider and vote on a proposal to approve an Mgmt For For
amendment to the Company's Certificate of
Incorporation to increase the total number of
authorized shares of Common Stock to 750,000,000
shares.

2. To consider and vote on a proposal, for purposes of Mgmt For For
complying with applicable NYSE American rules, to
approve the issuance by the Company of shares of
Common Stock, par value $0.001 per share, in an amount
equal to 20% or more of the amount of Company Common
Stock issued and outstanding immediately prior to such
issuance pursuant to the terms of the Merger
Agreement, in an amount necessary to complete the
Merger and the other transactions contemplated by the
Merger Agreement.

3. To consider and vote on a proposal to approve an Mgmt For For
amendment to the Company's Amended and Restated 2020
Equity Incentive Plan to increase the total number of
shares of common stock available for awards under the
Plan to 46,000,000 shares.

4. DIRECTOR
Lori A. Woods Mgmt For For
Philip J. Vitale, M.D. Mgmt For For
Michael W. McCormick Mgmt For For
Alan Hoffmann Mgmt For For

5. To ratify the appointment of Assure CPA, LLC as the Mgmt For For
independent registered public accounting firm of the
Company for the fiscal year ending June 30, 2023.

6. To hold an advisory vote to approve the compensation Mgmt For For
of the Company's named executive officers.

7. To consider and vote on a proposal to approve the Mgmt For For
adjournment of the Annual Meeting, if necessary, to
ensure that any necessary supplement or amendment to
the proxy statement accompanying this notice is
provided to the Company's stockholders a reasonable
amount of time in advance of the Annual Meeting or to
solicit additional proxies if there are insufficient
votes at the time of the Annual Meeting to approve
adoption of the Certificate Amendment Proposal, the
NYSE American Proposal, or the Equity Incentive Plan
Amendment Proposal.

--------------------------------------------------------------------------------------------------------------------------
JOURNEY MEDICAL CORPORATION Agenda Number: 935860521
--------------------------------------------------------------------------------------------------------------------------
Security: 48115J109 Meeting Type: Annual
Ticker: DERM Meeting Date: 21-Jun-2023
ISIN: US48115J1097
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Lindsay A. Rosenwald MD Mgmt For For
Claude Maraoui Mgmt For For
Neil Herskowitz Mgmt For For
Jeffrey Paley, M.D. PhD Mgmt For For
Justin Smith Mgmt For For
Miranda Toledano Mgmt For For

2. Ratify the appointment of KPMG LLP as the Company's Mgmt For For
independent registered public accounting firm for the
year ending December 31, 2023.

3. Approve the Journey Medical Corporation 2023 Employee Mgmt For For
Stock Purchase Plan.

--------------------------------------------------------------------------------------------------------------------------
MAGNITE, INC. Agenda Number: 935849539
--------------------------------------------------------------------------------------------------------------------------
Security: 55955D100 Meeting Type: Annual
Ticker: MGNI Meeting Date: 14-Jun-2023
ISIN: US55955D1000
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Paul Caine Mgmt For For

1b. Election of Director: Doug Knopper Mgmt For For

1c. Election of Director: David Pearson Mgmt For For

2. To ratify the selection of Deloitte & Touche LLP as Mgmt For For
the company's independent registered public accounting
firm for the current fiscal year.

3. To approve, on an advisory basis, of the compensation Mgmt For For
of the company's named executive officers.

4. To approve the Magnite, Inc. Amended and Restated 2014 Mgmt For For
Equity Incentive Plan.

5. To approve the Magnite, Inc. Amended and Restated 2014 Mgmt For For
Employee Stock Purchase Plan.

--------------------------------------------------------------------------------------------------------------------------
MDXHEALTH SA Agenda Number: 935862741
--------------------------------------------------------------------------------------------------------------------------
Security: 58286E102 Meeting Type: Annual
Ticker: MDXH Meeting Date: 25-May-2023
ISIN: US58286E1029
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

O2 Approval of the annual (non-consolidated) statutory Mgmt For
financial statements Proposed resolution: The general
shareholders' meeting resolves to approve the annual
(nonconsolidated) statutory financial statements of
the Company for the financial year ended on 31
December 2022 and to approve the allocation of the
annual result as proposed by the board of directors.

O4 Discharge from liability of the directors Proposed Mgmt For
resolution: The general shareholders' meeting resolves
to grant discharge from liability to each of the
directors who was in office during the financial year
ended on 31 December 2022, for the performance of its,
his or her mandate during that financial year.

O5 Discharge from liability of the statutory auditor Mgmt For
Proposed resolution: The general shareholders' meeting
resolves to grant discharge from liability to the
statutory auditor which was in office during the
financial year ended on 31 December 2022, for the
performance of its mandate during that financial year.

O6 Remuneration report Proposed resolution: The general Mgmt For
shareholders' meeting resolves to approve the
remuneration report included in the combined annual
report of the board of directors on the consolidated
and (non-consolidated) statutory financial statements
of the Company for the financial year ended on 31
December 2022.

O7a Re-appointment of director Proposed resolution: The Mgmt For
general shareholders' meeting resolves to re-appoint
Hilde Windels BV, represented by Hilde Windels as
permanent representative, ...(due to space limits, see
proxy material for full proposal).

O7b Re-appointment of director Proposed resolution: The Mgmt Take No Action
general shareholders' meeting resolves to re-appoint
Regine Slagmulder BV, represented by Regine Slagmulder
as permanent representative, as independent director
of the Company within ...(due to space limits, see
proxy material for full proposal).

O7c Re-appointment of director Proposed resolution: The Mgmt For
general shareholders' meeting resolves to re-appoint
Eric Bednarski as director of the Company, for a term
of two years, up to and ...(due to space limits, see
proxy material for full proposal).

O7d Re-appointment of director Proposed resolution: The Mgmt For
general shareholders' meeting resolves to re-appoint
Michael K. McGarrity as director of the Company, for a
term of three years, ...(due to space limits, see
proxy material for full proposal).

O8 Re-appointment of the statutory auditor Proposed Mgmt For
resolution: Taking into account the recommendation of
the board of directors upon recommendation and
preference of the audit committee, ...(due to space
limits, see proxy material for full proposal).

O9 Approval in accordance with article 7:151 of the Mgmt For
Belgian ...(due to space limits, see proxy material
for full proposal).

E2 Proposal to issue 5,000,000 2023 Share Options: Mgmt For
Proposed ...(due to space limits, see proxy material
for full proposal).

E4 Renewal of the authorisation to the board of directors Mgmt For
to ...(due to space limits, see proxy material for
full proposal).

--------------------------------------------------------------------------------------------------------------------------
MDXHEALTH SA Agenda Number: 935893962
--------------------------------------------------------------------------------------------------------------------------
Security: 58286E102 Meeting Type: Special
Ticker: MDXH Meeting Date: 30-Jun-2023
ISIN: US58286E1029
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

2. The general shareholders' meeting resolves to approve Mgmt For
the issuance of 5,000,000 2023 Share Options, pursuant
to a share option plan named the "2023 Share Option
Plan", and to dis-apply, in the interest of the
Company, the preferential subscription right of the
existing shareholders of the Company and, insofar as
required, of the holders of outstanding subscription
rights (share options) or ADSs of the Company, for the
benefit of Selected Participant. In view thereof, the
...(due to space limits,see proxy material for full
proposal).

4. The general shareholders' meeting resolves to renew Mgmt For
the authorisation to the board of directors to
increase the share capital in one or several times,
during a period of five (5) years as from the
publication in the Annexes to the Belgian Official
Gazette of this authorisation, with an aggregate
amount equal to up to 100% of the amount of the share
capital of the Company, and this in accordance with
the terms and conditions set forth in the special
report of the board of directors ...(due to space
limits, see proxy material for full proposal).

--------------------------------------------------------------------------------------------------------------------------
NATERA, INC. Agenda Number: 935840529
--------------------------------------------------------------------------------------------------------------------------
Security: 632307104 Meeting Type: Annual
Ticker: NTRA Meeting Date: 09-Jun-2023
ISIN: US6323071042
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Rowan Chapman Mgmt For For
Herm Rosenman Mgmt For For
Jonathan Sheena Mgmt For For

2. To ratify the appointment of Ernst & Young LLP as Mgmt For For
Natera, Inc.'s independent registered public
accounting firm for the fiscal year ending December
31, 2023.

3. To approve, on an advisory (non-binding) basis, the Mgmt For For
compensation of Natera, Inc.'s named executive
officers as disclosed in the proxy statement.

--------------------------------------------------------------------------------------------------------------------------
NEOGENOMICS, INC. Agenda Number: 935816388
--------------------------------------------------------------------------------------------------------------------------
Security: 64049M209 Meeting Type: Annual
Ticker: NEO Meeting Date: 25-May-2023
ISIN: US64049M2098
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Lynn A. Tetrault Mgmt For For

1b. Election of Director: Christopher M. Smith Mgmt For For

1c. Election of Director: Bruce K. Crowther Mgmt For For

1d. Election of Director: Dr. Alison L. Hannah Mgmt For For

1e. Election of Director: Stephen M. Kanovsky Mgmt For For

1f. Election of Director: Michael A. Kelly Mgmt For For

1g. Election of Director: David B. Perez Mgmt For For

1h. Election of Director: Rachel A. Stahler Mgmt For For

2. Approval, on an advisory basis, of the Compensation Mgmt For For
Paid to the Company's Named Executive Officers.

3. Approval of the NeoGenomics, Inc. 2023 Equity Mgmt For For
Incentive Plan.

4. Ratification of the Appointment of Deloitte & Touche Mgmt For For
LLP as the Company's Independent Registered Public
Accounting Firm.

--------------------------------------------------------------------------------------------------------------------------
OPTIMIZERX CORPORATION Agenda Number: 935833548
--------------------------------------------------------------------------------------------------------------------------
Security: 68401U204 Meeting Type: Annual
Ticker: OPRX Meeting Date: 07-Jun-2023
ISIN: US68401U2042
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
William J. Febbo Mgmt For For
Gus D. Halas Mgmt For For
Lynn O'Connor Vos Mgmt For For
James Lang Mgmt For For
Patrick Spangler Mgmt For For
Gregory D. Wasson Mgmt For For

2. Advisory approval of the compensation of our named Mgmt For For
executive officers.

3. Ratification of UHY LLP as OptimizeRx's independent Mgmt For For
registered public accounting firm for the 2023 fiscal
year.

--------------------------------------------------------------------------------------------------------------------------
OPTION CARE HEALTH, INC. Agenda Number: 935812758
--------------------------------------------------------------------------------------------------------------------------
Security: 68404L201 Meeting Type: Annual
Ticker: OPCH Meeting Date: 17-May-2023
ISIN: US68404L2016
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
John J. Arlotta Mgmt For For
Elizabeth Q. Betten Mgmt For For
Elizabeth D. Bierbower Mgmt For For
Natasha Deckmann Mgmt For For
David W. Golding Mgmt For For
Harry M. J. Kraemer Jr. Mgmt For For
R. Carter Pate Mgmt For For
John C. Rademacher Mgmt For For
Nitin Sahney Mgmt For For
Timothy P. Sullivan Mgmt For For

2. To ratify the appointment of KPMG LLP as our Mgmt For For
independent registered public accounting firm for the
year ending December 31, 2023.

3. To approve, on a non-binding advisory basis, our Mgmt For For
executive compensation.

4. To conduct an advisory vote on the frequency of a Mgmt 1 Year For
stockholder vote on our executive compensation.

--------------------------------------------------------------------------------------------------------------------------
PERFICIENT, INC. Agenda Number: 935830984
--------------------------------------------------------------------------------------------------------------------------
Security: 71375U101 Meeting Type: Annual
Ticker: PRFT Meeting Date: 07-Jun-2023
ISIN: US71375U1016
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Romil Bahl Mgmt For For

1b. Election of Director: Jeffrey S. Davis Mgmt For For

1c. Election of Director: Ralph C. Derrickson Mgmt For For

1d. Election of Director: Jill A. Jones Mgmt For For

1e. Election of Director: David S. Lundeen Mgmt For For

1f. Election of Director: Brian L. Matthews Mgmt For For

1g. Election of Director: Nancy C. Pechloff Mgmt For For

1h. Election of Director: Gary M. Wimberly Mgmt For For

2. Proposal to approve, on an advisory basis, the Mgmt 1 Year For
frequency of the future advisory vote on executive
compensation.

3. Proposal to approve, on an advisory basis, a Mgmt For For
resolution relating to the 2022 compensation of the
named executive officers.

4. Proposal to approve the Third Amended and Restated Mgmt For For
Perficient, Inc. 2012 Long Term Incentive Plan.

5. Proposal to amend and restate the Company's Mgmt For For
Certificate of Incorporation to permit the exculpation
of officers.

6. Proposal to ratify KPMG LLP as Perficient, Inc.'s Mgmt For For
independent registered public accounting firm for the
2023 fiscal year.

--------------------------------------------------------------------------------------------------------------------------
PERION NETWORK LTD Agenda Number: 935889696
--------------------------------------------------------------------------------------------------------------------------
Security: M78673114 Meeting Type: Annual
Ticker: PERI Meeting Date: 21-Jun-2023
ISIN: IL0010958192
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. To approve the re-election of Ms. Joy Marcus to serve Mgmt For For
as a director of the Company until the third annual
general meeting of shareholders of the Company
following this meeting or her earlier resignation or
removal, as applicable.

1b. To approve the re-election of Mr. Michael Vorhaus to Mgmt For For
serve as a director of the Company until the third
annual general meeting of shareholders of the Company
following this meeting or his earlier resignation or
removal, as applicable.

2. To approve the amendments of the Articles of Mgmt For For
Association and Memorandum of Association of the
Company to reflect the increase of the authorized
share capital of the Company, as detailed in the Proxy
Statement, dated May 17, 2023.

3. To approve amendments to the terms of employment of Mgmt For For
Mr. Tal Jacobson in connection with his appointment as
the Company's Chief Executive Officer, as detailed in
the Proxy Statement, dated May 17, 2023.

3a. Are you a controlling shareholder (as defined in the Mgmt Against
Proxy Statement) or do you have a personal interest
(as defined in the Proxy Statement) in the approval of
Proposal 3? (Please note: If you do not mark either
'Yes' or 'No', your shares will not be voted for this
Proposal). Mark "for" = yes or "against" = no.

4. To appoint Kost Forer Gabbay & Kasierer, a member of Mgmt For For
Ernst & Young Global, as the independent public
auditors of the Company for the year ending on
December 31, 2023, and until the next annual general
meeting of shareholders, and that the board of
directors of the Company, upon the recommendation of
the audit committee of the Company, is authorized to
determine the compensation of said independent
auditors in accordance with the volume and nature of
their services.

--------------------------------------------------------------------------------------------------------------------------
ROCKWELL MEDICAL, INC. Agenda Number: 935843311
--------------------------------------------------------------------------------------------------------------------------
Security: 774374300 Meeting Type: Annual
Ticker: RMTI Meeting Date: 23-May-2023
ISIN: US7743743004
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Director: Mark H. Ravich Mgmt For For

1b. Election of Director: Andrea Heslin Smiley Mgmt For For

2. Approve, on an advisory basis, the compensation of the Mgmt For For
Company's named executive officers.

3. Approve, on an advisory basis, the frequency of Mgmt 1 Year For
stockholder advisory votes on the compensation of the
Company's named executive officers.

4. Ratify the selection of EisnerAmper LLP as the Mgmt For For
Company's independent registered public accounting
firm for 2023.

5. Approve an amendment and restatement of the Rockwell Mgmt For For
Medical, Inc. 2018 Long Term Incentive Plan to
increase the number of shares reserved for issuance
thereunder by 1,600,000 shares.

--------------------------------------------------------------------------------------------------------------------------
STREAMLINE HEALTH SOLUTIONS, INC. Agenda Number: 935872122
--------------------------------------------------------------------------------------------------------------------------
Security: 86323X106 Meeting Type: Annual
Ticker: STRM Meeting Date: 15-Jun-2023
ISIN: US86323X1063
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1.1 Election of Director to serve until the 2024 Annual Mgmt For For
Meeting: Wyche T. "Tee" Green, III

1.2 Election of Director to serve until the 2024 Annual Mgmt For For
Meeting: Justin J. Ferayorni

1.3 Election of Director to serve until the 2024 Annual Mgmt For For
Meeting: Kenan H. Lucas

1.4 Election of Director to serve until the 2024 Annual Mgmt For For
Meeting: Jonathan R. Phillips

1.5 Election of Director to serve until the 2024 Annual Mgmt For For
Meeting: Judith E. Starkey

2. To approve, on a non-binding advisory basis, the Mgmt For For
compensation of our named executive officers
("say-on-pay").

3. To ratify the appointment of the firm of FORVIS, LLP Mgmt For For
to serve as our independent registered public
accounting firm for fiscal year 2023.

4. To approve an amendment to the Streamline Health Mgmt For For
Solutions, Inc. Third Amended and Restated 2013 Stock
Incentive Plan (the "Plan"), to increase the number of
shares of common stock available for issuance under
the Plan.

--------------------------------------------------------------------------------------------------------------------------
TACTILE SYSTEMS TECHNOLOGY, INC. Agenda Number: 935791625
--------------------------------------------------------------------------------------------------------------------------
Security: 87357P100 Meeting Type: Annual
Ticker: TCMD Meeting Date: 08-May-2023
ISIN: US87357P1003
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Valerie Asbury Mgmt For For
Bill Burke Mgmt For For
Sheri Dodd Mgmt For For
Raymond Huggenberger Mgmt For For
Daniel Reuvers Mgmt For For
Brent Shafer Mgmt For For
Carmen Volkart Mgmt For For

2. Ratify the appointment of Grant Thornton LLP as our Mgmt For For
independent registered public accounting firm for the
year ending December 31, 2023.

3. Approve, on an advisory basis, the 2022 compensation Mgmt For For
of our named executive officers.

--------------------------------------------------------------------------------------------------------------------------
UPHEALTH, INC. Agenda Number: 935739613
--------------------------------------------------------------------------------------------------------------------------
Security: 91532B101 Meeting Type: Annual
Ticker: UPH Meeting Date: 05-Dec-2022
ISIN: US91532B1017
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Samuel J. Meckey Mgmt For For
Luis Machuca Mgmt For For
Mark Guinan Mgmt For For

2. Ratification of BPM LLP as our independent registered Mgmt For For
public accounting firm.

3. Amendment to Second Amended and Restated Certificate Mgmt For For
of Incorporation to effect a reverse stock split of
our common stock, at a specific ratio within a range
of 4:1 to 10:1 to be fixed by the Board of Directors.

--------------------------------------------------------------------------------------------------------------------------
VERACYTE, INC. Agenda Number: 935840581
--------------------------------------------------------------------------------------------------------------------------
Security: 92337F107 Meeting Type: Annual
Ticker: VCYT Meeting Date: 08-Jun-2023
ISIN: US92337F1075
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1a. Election of Class I Director to serve until the 2026 Mgmt For For
Annual Meeting of Stockholders: Robert S. Epstein

1b. Election of Class I Director to serve until the 2026 Mgmt For For
Annual Meeting of Stockholders: Evan Jones

2. The ratification of the appointment of Ernst & Young Mgmt For For
LLP as our independent registered public accounting
firm for 2023.

3. The approval, on a non-binding advisory basis, of the Mgmt For For
compensation of our named executive officers, as
disclosed in our proxy statement.

4. The approval of the new Veracyte, Inc. 2023 Equity Mgmt For For
Incentive Plan.

5. The adoption of an amendment to our existing restated Mgmt For For
certificate of incorporation in order to declassify
our Board of Directors and make other related changes.

6. The adoption of an amendment to our existing restated Mgmt For For
certificate of incorporation to permit exculpation of
officers by Veracyte from personal liability for
certain breaches of the duty of care.

--------------------------------------------------------------------------------------------------------------------------
VERICEL CORPORATION Agenda Number: 935786674
--------------------------------------------------------------------------------------------------------------------------
Security: 92346J108 Meeting Type: Annual
Ticker: VCEL Meeting Date: 03-May-2023
ISIN: US92346J1088
--------------------------------------------------------------------------------------------------------------------------

Prop.# Proposal Proposal Proposal Vote For/Against
Type Management

1. DIRECTOR
Robert L. Zerbe Mgmt For For
Alan L. Rubino Mgmt For For
Heidi Hagen Mgmt For For
Steven C. Gilman Mgmt For For
Kevin F. McLaughlin Mgmt For For
Paul K. Wotton Mgmt For For
Dominick C. Colangelo Mgmt For For
Lisa Wright Mgmt For For

2. To approve, on an advisory basis, the compensation of Mgmt For For
Vericel Corporation's named executive officers.

3. To ratify the appointment of PricewaterhouseCoopers Mgmt For For
LLP as Vericel Corporation's independent registered
public accounting firm for the fiscal year ending
December 31, 2023.

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

World Funds Trust

(Registrant)

By /s/ Karen Shupe

Name: Karen Shupe

Title: Principal Executive Officer

Date: August 29, 2023